https://www.selleckchem.com/Bcl-2.html
h CAD. Clinical trial registration Nos. NCT03068858 and NCT02880605; https//www.clinicaltrials.gov.Background The transforming growth factor β1 (TGF-β1)-induced epithelial-mesenchymal transition (EMT) has been proven associated with the pathogenesis of asthmatic airway remodeling, in which the Wnt/β-catenin pathway plays an important role, notably with regard to TGF-β1. Recent studies have shown that 1α, 25-dihydroxyvitamin D3(1α, 25(OH)2D3) inhibits TGF-β1-induced EMT, although the underlying mechanism have not yet been fully elucidated. Methods
Like
Comment
Share
